These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24467601)

  • 1. Nose to brain microemulsion-based drug delivery system of rivastigmine: formulation and ex-vivo characterization.
    Shah BM; Misra M; Shishoo CJ; Padh H
    Drug Deliv; 2015; 22(7):918-30. PubMed ID: 24467601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and In-vivo Pharmacokinetic Consideration of Intranasal Microemulsion and Mucoadhesive Microemulsion of Rivastigmine for Brain Targeting.
    Shah B; Khunt D; Misra M; Padh H
    Pharm Res; 2018 Jan; 35(1):8. PubMed ID: 29294189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic development of lectin conjugated microspheres for nose-to-brain delivery of rivastigmine for the treatment of Alzheimer's disease.
    Gao Y; Almalki WH; Afzal O; Panda SK; Kazmi I; Alrobaian M; Katouah HA; Altamimi ASA; Al-Abbasi FA; Alshehri S; Soni K; Ibrahim IAA; Rahman M; Beg S
    Biomed Pharmacother; 2021 Sep; 141():111829. PubMed ID: 34147904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and characterization of nanoemulsion of olanzapine for intranasal delivery.
    Kumar M; Misra A; Pathak K
    PDA J Pharm Sci Technol; 2009; 63(6):501-11. PubMed ID: 20169856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive intranasal delivery of quetiapine fumarate loaded microemulsion for brain targeting: Formulation, physicochemical and pharmacokinetic consideration.
    Shah B; Khunt D; Misra M; Padh H
    Eur J Pharm Sci; 2016 Aug; 91():196-207. PubMed ID: 27174656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic and pharmacodynamic evaluation of nasal liposome and nanoparticle based rivastigmine formulations in acute and chronic models of Alzheimer's disease.
    Rompicherla SKL; Arumugam K; Bojja SL; Kumar N; Rao CM
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Aug; 394(8):1737-1755. PubMed ID: 34086100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, development and in-vitro/in-vivo evaluation of intranasally delivered Rivastigmine and N-Acetyl Cysteine loaded bifunctional niosomes for applications in combinative treatment of Alzheimer's disease.
    Kulkarni P; Rawtani D; Barot T
    Eur J Pharm Biopharm; 2021 Jun; 163():1-15. PubMed ID: 33774160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal microemulsion of sildenafil citrate: in vitro evaluation and in vivo pharmacokinetic study in rabbits.
    Elshafeey AH; Bendas ER; Mohamed OH
    AAPS PharmSciTech; 2009; 10(2):361-7. PubMed ID: 19333762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of quality by design approach for intranasal delivery of rivastigmine loaded solid lipid nanoparticles: Effect on formulation and characterization parameters.
    Shah B; Khunt D; Bhatt H; Misra M; Padh H
    Eur J Pharm Sci; 2015 Oct; 78():54-66. PubMed ID: 26143262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a Nasal Donepezil-loaded Microemulsion for the Treatment of Alzheimer's Disease: in vitro and ex vivo Characterization.
    Espinoza LC; Vacacela M; Clares B; Garcia ML; Fabrega MJ; Calpena AC
    CNS Neurol Disord Drug Targets; 2018 Apr; 17(1):43-53. PubMed ID: 29299992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and characterization of nanoemulsion-based drug delivery system of risperidone.
    Kumar M; Pathak K; Misra A
    Drug Dev Ind Pharm; 2009 Apr; 35(4):387-95. PubMed ID: 19016058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nose-to-Brain Targeted Delivery of Donepezil Hydrochloride via Novel Hyaluronic Acid-Doped Nanotransfersomes for Alzheimer's Disease Mitigation.
    Salem HF; Aboud HM; Abdellatif MM; Abou-Taleb HA
    J Pharm Sci; 2024 Jul; 113(7):1934-1945. PubMed ID: 38369023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoemulsions for Intranasal Delivery of Riluzole to Improve Brain Bioavailability: Formulation Development and Pharmacokinetic Studies.
    Parikh RH; Patel RJ
    Curr Drug Deliv; 2016; 13(7):1130-1143. PubMed ID: 26638977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain targeting of chitosan-based diazepam mucoadhesive microemulsions via nasal route: formulation optimization, characterization, pharmacokinetic and pharmacodynamic evaluation.
    Ramreddy S; Janapareddi K
    Drug Dev Ind Pharm; 2019 Jan; 45(1):147-158. PubMed ID: 30230386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and characterization of microemulsion of cilostazol for enhancement of oral bioavailability.
    Patel SG; Rajput SJ; Groshev A; Sutariya VB
    Curr Drug Deliv; 2014; 11(4):531-40. PubMed ID: 24274587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buffered nanoemulsion for nose to brain delivery of ziprasidone hydrochloride: preformulation and pharmacodynamic evaluation.
    Bahadur S; Pathak K
    Curr Drug Deliv; 2012 Nov; 9(6):596-607. PubMed ID: 22788695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microemulsion based intranasal delivery system for treatment of insomnia.
    Porecha S; shah T; Jogani V; Naik S; Misra A
    Drug Deliv; 2009 Apr; 16(3):128-34. PubMed ID: 19514972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal microemulsion for targeted nose to brain delivery in neurocysticercosis: Role of docosahexaenoic acid.
    Shinde RL; Bharkad GP; Devarajan PV
    Eur J Pharm Biopharm; 2015 Oct; 96():363-79. PubMed ID: 26318978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal mucoadhesive microemulsion of tacrine to improve brain targeting.
    Jogani VV; Shah PJ; Mishra P; Mishra AK; Misra AR
    Alzheimer Dis Assoc Disord; 2008; 22(2):116-24. PubMed ID: 18525282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced brain distribution and pharmacodynamics of rivastigmine by liposomes following intranasal administration.
    Yang ZZ; Zhang YQ; Wang ZZ; Wu K; Lou JN; Qi XR
    Int J Pharm; 2013 Aug; 452(1-2):344-54. PubMed ID: 23680731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.